370 related articles for article (PubMed ID: 30078165)
21. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
22. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
Qing X; Qing A; Ji P; French SW; Mason H
Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
[TBL] [Abstract][Full Text] [Related]
23. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
[TBL] [Abstract][Full Text] [Related]
24. Secondary chronic myeloid leukemia following acute myeloid leukemia treated with autologous hematopoietic stem cell transplantation: a case report.
Cheng J; Liao Y; Bin T; OUYang J; Chen S; Chen X; Zou W
Curr Med Res Opin; 2020 Nov; 36(11):1807-1812. PubMed ID: 32936052
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.
Jain P; Kantarjian HM; Ghorab A; Sasaki K; Jabbour EJ; Nogueras Gonzalez G; Kanagal-Shamanna R; Issa GC; Garcia-Manero G; Kc D; Dellasala S; Pierce S; Konopleva M; Wierda WG; Verstovsek S; Daver NG; Kadia TM; Borthakur G; O'Brien S; Estrov Z; Ravandi F; Cortes JE
Cancer; 2017 Nov; 123(22):4391-4402. PubMed ID: 28743165
[TBL] [Abstract][Full Text] [Related]
26. Prolonged Survival of a Patient with Chronic Myeloid Leukemia in Accelerated Phase with Recurrent Isolated Central Nervous System Blast Crisis.
Bin Salman AA; Zaidi ARZ; Altaf SY; AlShehry NF; Tailor IK; Motabi IH; Zaidi SZA
Am J Case Rep; 2020 Sep; 21():e922971. PubMed ID: 32920590
[TBL] [Abstract][Full Text] [Related]
27. Transplant to treatment-free remission: the evolving view of 'cure' in chronic myeloid leukemia.
Yong AS; Brissot E; Rubinstein S; Savani BN; Mohty M
Expert Rev Hematol; 2015 Dec; 8(6):785-97. PubMed ID: 26364871
[TBL] [Abstract][Full Text] [Related]
28. Autologous peripheral stem cell transplantation of the blastic phase of chronic myeloid leukemia following sequential high-dose cytosine arabinoside and melphalan.
Matulonis UA; Griffin JD; Canellos GP
Am J Hematol; 1994 Apr; 45(4):283-7. PubMed ID: 7909981
[TBL] [Abstract][Full Text] [Related]
29. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
30. The evolving role of bone marrow transplantation in the treatment of chronic myelogenous leukemia.
Delage R; Ritz J; Anderson KC
Hematol Oncol Clin North Am; 1990 Apr; 4(2):369-88. PubMed ID: 2182597
[TBL] [Abstract][Full Text] [Related]
31. Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation.
Oshima K; Kanda Y; Yamashita T; Takahashi S; Mori T; Nakaseko C; Fujimaki K; Yokota A; Fujisawa S; Matsushima T; Fujita H; Sakura T; Okamoto S; Maruta A; Sakamaki H;
Biol Blood Marrow Transplant; 2008 Oct; 14(10):1100-1107. PubMed ID: 18804039
[TBL] [Abstract][Full Text] [Related]
32. The addition of daunorubicin to imatinib mesylate in combination with cytarabine improves the response rate and the survival of patients with myeloid blast crisis chronic myelogenous leukemia (AFR01 study).
Deau B; Nicolini FE; Guilhot J; Huguet F; Guerci A; Legros L; Pautas C; Berthou C; Guyotat D; Cony-Makhoul P; Gardembas M; Michallet M; Hayette S; Cayuela JM; Weiss IR; Réa D; Castaigne S; Mahon FX; Guilhot F; Rousselot P
Leuk Res; 2011 Jun; 35(6):777-82. PubMed ID: 21145590
[TBL] [Abstract][Full Text] [Related]
33. When to Consider Allogeneic Transplantation in CML.
Radich J
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S93-5. PubMed ID: 27521333
[TBL] [Abstract][Full Text] [Related]
34. Extramedullary blast crisis of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation mimicking aggressive, translocation t(14;18)-positive B-cell lymphoma.
Kroschinsky F; Friedrich K; Hanel M; Mohr B; Langer T; Meinhardt M; Thiede C; Bornhauser M; Baretton G; Ehninger G
Ann Hematol; 2003 Jan; 82(1):47-52. PubMed ID: 12574966
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow cytogenetic complete remission achieved by interferon-alpha plus cytarabine ocfosfate therapy in a patient with chronic myelogenous leukemia during extramedullary blast crisis.
Gotoh A; Miyazawa K; Uchida Y; Sashida G; Kawakubo K; Kuriyama Y; Ohyashiki K
Int J Hematol; 2002 Feb; 75(2):191-4. PubMed ID: 11939268
[TBL] [Abstract][Full Text] [Related]
36. Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: a preliminary assessment.
Simon W; Segel GB; Lichtman MA
Blood Cells Mol Dis; 2006; 37(2):116-24; discussion 125-7. PubMed ID: 16904348
[TBL] [Abstract][Full Text] [Related]
37. Characterisation of extramedullary relapse in patients with chronic myeloid leukemia in advanced disease after allogeneic stem cell transplantation.
Ocheni S; Iwanski GB; Schafhausen P; Zander AR; Ayuk F; Klyuchnikov E; Zabelina T; Fiedler W; Schnittger S; Hochhaus A; Brümmendorf TH; Kröger N; Bacher U
Leuk Lymphoma; 2009 Apr; 50(4):551-8. PubMed ID: 19373652
[TBL] [Abstract][Full Text] [Related]
38. Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy.
Aichberger KJ; Herndlhofer S; Agis H; Sperr WR; Esterbauer H; Rabitsch W; Knöbl P; Haas OA; Thalhammer R; Schwarzinger I; Sillaber C; Jäger U; Valent P
Eur J Clin Invest; 2007 Oct; 37(10):808-13. PubMed ID: 17727673
[TBL] [Abstract][Full Text] [Related]
39. A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Elmaagacli AH; Beelen DW; Schaefer UW
Bone Marrow Transplant; 1997 Dec; 20(12):1045-55. PubMed ID: 9466277
[TBL] [Abstract][Full Text] [Related]
40. Isolated central nervous system relapse in two patients with BCR-ABL-positive acute leukemia while receiving a next-generation tyrosine kinase inhibitor.
Gaur S; Torabi AR; Corral J
In Vivo; 2014; 28(6):1149-53. PubMed ID: 25398814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
